XML 13 R6.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income (loss) $ (106,115) $ (195,805)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation, depletion, amortization and accretion expense 530,600 613,362
Impairment of oil and natural gas properties 145,018 223,881
Amortization of deferred financing costs and original issue discount 3,862 3,695
Equity-based compensation expense 11,745 8,544
Price risk management activities (income) expense 142,998 (71,002)
Net cash received (paid) on settled derivative instruments (96,616) 38,482
Equity method investment (income) expense (6,557) 676
Settlement of asset retirement obligations (40,571) (38,249)
Loss (gain) on sale of assets 1,564 (16)
Changes in operating assets and liabilities:    
Accounts receivable (11,096) 63,863
Other current assets (57,931) 24,361
Accounts payable 333 (2,451)
Other current liabilities 3,631 (9,244)
Other non-current assets and liabilities, net (46,228) (40,219)
Net cash provided by (used in) operating activities 474,637 619,878
Cash flows from investing activities:    
Exploration, development and other capital expenditures (254,037) (276,149)
Payments for acquisitions, net of cash acquired (3,125) (14,845)
Proceeds from (cash paid for) sale of property and equipment, net 15,027 687
Contributions to equity method investees 0 (1,996)
Proceeds from sale of equity method investments 49,665  
Net cash provided by (used in) investing activities (192,470) (292,303)
Cash flows from financing activities:    
Deferred financing costs (7,349) 0
Other deferred payments (4,548) (10,172)
Payments of finance lease (10,528) (9,616)
Purchase of treasury stock (38,203) (54,736)
Employee stock awards tax withholdings (5,945) (2,399)
Net cash provided by (used in) financing activities (66,573) (76,923)
Net increase (decrease) in cash, cash equivalents and restricted cash 215,594 250,652
Cash, cash equivalents and restricted cash:    
Balance, beginning of period 438,990 214,432
Balance, end of period 654,584 465,084
Supplemental non-cash transactions:    
Capital expenditures included in accounts payable and accrued liabilities 59,974 48,926
Supplemental cash flow information:    
Interest paid, net of amounts capitalized $ 57,618 $ 59,769